Enzymes The Heart Defender

Enzymes: The Heart Defender, by Michael W. Loes M.D.

Researchers have found that having high antibodies to chlamydia pneumoniae predispose people to a second heart attack. Dr. Sandeep Gupta, of St. George's Hospital, London reported that in his patients, when there was evidence of chlamydia, heart problems quadrupled over an eighteen month period. The British researcher has found that antibiotics seemed to reduce the incidence of recurrent heart attacks - a three day course of azithromycin, certainly deserving of further study.

Floss Your Teeth or Die of Heart Disease!

Do you floss your teeth as often as you should? You might want to be sure you do-especially after learning about this third troublemaker, Porphyomonas gingivitis.

This bacterial agent is known largely responsible for its role in causing gum disease, but recent data involving its relationship to heart disease deserves attention. Dr. Raul Garcia of the Boston Veteran's Hospital, as part of the Normative Aging Study, reviewed the cumulative twenty-five year data on over one thousand men. The men with terrible gum disease had twice the incidence of heart attacks compared to healthy peers. Their stroke rate was three times as high. At the scene of the crime was crime was Porphyomonas gingivitis.

Why might oral systemic enzymes be helpful here?

The science behind enzymes is substantial, especially in relationship to their role as biological response modifiers; enzymes enhance the healing response. But you ask, "What do enzymes do? Why do they work? In simple terms, they help cell signaling, assisting cells in knowing what to do and when. The immune system is complicated, but we know a lot, especially in regards to how enzymes speed up healing and prevent edema and scarring processes.

Enzymes are involved in all of the following and more:

  • Induction of optimal amounts of tumor necrosis factor and interleukins. Systemic oral enzymes lead to a dose-dependent increased formation of tumor necrosis factor (TNF-a), interleukin 1-b and interleukin 6. These tough cops kill dangerous cells and cancer tissues circulating in the body, as well as mount attacks on bacteria and viruses. 12
  • Macrophage and killer activation. The activity of bacteria-consuming macrophages is increased up to 700 percent within 10 minutes following the start of systemic oral enzyme therapy. 8 The activity of natural killer cells went up 1,300 percent during the same time. 13, 17
  • Selective Destruction of Infectious Agents. When proteolytic enzymes are added to bacterial cell cultures, loss of bacterial nuclei occur, and loss of cell architecture takes place; the bacteria die and their debris is removed via enzymatic processes. 14, 15 � The Master Cytokine - Transforming Growth Hormone, beta factor, is kept in check, being reduced in processes where fibrosis and scarring are likely to occur. 16,17,18

Are you interested in doing what you can to help reduce chronic inflammation as it relates to the heart disease? Of course you are. Defend Your Heart with Systemic Oral Enzymes!


  1. NEJM 343(2) 78-85 2000
  2. Maseri, A., Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon" The New England Journal of Medicine, 1997; 336(14) 1014-16
  3. Inflammation and the Heart: Nutrition Action Health Letter, June 1997: 14
  4. Ridker, P.M., et al. "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men." The New England Journal of Medicine, 1997; 336(14); 973-079, 1416-1418
  5. Loes, MW., Steinman, D, The Aspirin Alternative, "Escape the Toxicity of NSAIDs, Freedom Press, June 1999, ISBN 1-893910-04-0
  6. Lazarou, P. et al. "Incidence of adverse drug reactions in hospitalized patients: meta-analysis of prospective studies." Journal of the American Medical Association, 1998; 279; 1200-1204
  7. Ibid, 5, p151
  8. Ibid, 5, p152
  9. Ibid, 5, p153
  10. Ibid, 5, p155
  11. Ibid, 2, p1014
  12. Enzymetherapie. Vienna: Maudrich Verlag, 1970
  13. Leskovar, P. "AIDS: Neuartige therapiekonzepte, Dtsch. Zeitschr. Onkol, 1990;2
  14. Rosanova, A., "Der gegenwartige stand der enzymtherapie bei malignen tumoren." Arzt. Praxis, 1974; 16, 1442
  15. Enzymetherapie. Vienna: Maudrich Verlag, 1970
  16. Blobe, GD, Schiemann, WP, Lodish, HS, "Role of Transforming Growth Hormone, NEJM, v342, No 18, April, 2000
  17. Kunze, R., Unpublished in vivo studies, personal communication, Oct 14, 1997
  18. Vinzenz, K., "odembehandlung bei zahnchirurgischen eingriffen mit hydrolytischen enzymen" Die Quintessenz, 1991; 7: 1053

McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
authorize.net certificate seal, secure customer transactions.